Peninsula startup’s all-star lineup, fresh off $197M round, circles next-generation cell therapies against cancer, other diseases
June 17, 2020 at 16:11 PM EDT
The former StartX accelerator company has raised $300 million over four years with the hopes of taking cell therapies into genetic diseases and autoimmune disorders.
